Edwards Lifesciences (Switzerland)

Edwards Lifesciences (Switzerland)

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Edwards Lifesciences (Switzerland), Switzerland, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

65%


Total
Publications

416


Total Open
Publications

270


Total
Citations

11K


Open Access
Percentage

65%


Total
Publications

416


Total Open
Publications

270


Total
Citations

11K

Wikipedia

Website

Download

Breakdown

31% 27% 7% 35%

Publisher Open

31%

Both

27%

Other Platform Open

7%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045505560Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

65

Hybrid 50%

121

No Guarantees 23%

55

Other Platform Open

Domain 82%

115

Institution 34%

48

Public 6%

9

Preprint 2%

3

Other Internet 2%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
114
Europe PMC
Domain
77
Semantic Scholar
Public
8
California Digital Library - eScholarship
Institution
5
University of California - eScholarship University of California
Institution
4
East Carolina University - The Scholarship East Carolina University's Institutional Repository
Institution
4
University of Toronto - TSpace
Institution
3
University of Helsinki - Helda
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
3
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
3
1 / 6

Data updated 27 September 2022

Share

Share

Share